(1) There is created the Health Reform Task Force consisting of the following 11 members: (a) four members of the Senate appointed by the president of the Senate, no more than three of whom are from the same political party; and (b) seven members of the House of Representatives appointed by the speaker of the House of Representatives, no more than five of whom are from the same political party.

(a) four members of the Senate appointed by the president of the Senate, no more than three of whom are from the same political party; and

(b) seven members of the House of Representatives appointed by the speaker of the House of Representatives, no more than five of whom are from the same political party.

(2) (a) The president of the Senate shall designate a member of the Senate appointed under Subsection (1)(a) as a cochair of the task force. (b) The speaker of the House of Representatives shall designate a member of the House of Representatives appointed under Subsection (1)(b) as a cochair of the task force.

(a) The president of the Senate shall designate a member of the Senate appointed under Subsection (1)(a) as a cochair of the task force.

(b) The speaker of the House of Representatives shall designate a member of the House of Representatives appointed under Subsection (1)(b) as a cochair of the task force.

(3) Salaries and expenses of the members of the task force shall be paid in accordance with Section 36-2-2 and Legislative Joint Rules, Title 5, Chapter 3, Legislator Compensation.

(4) The Office of Legislative Research and General Counsel shall provide staff support to the task force.

(5) The task force shall review and make recommendations on health system reform, including the following issues: (a) the need for state statutory and regulatory changes in response to federal actions affecting health care; (b) Medicaid and reforms to the Medicaid program; (c) options for increasing state flexibility, including the use of federal waivers; (d) the state's health insurance marketplace; (e) health insurance code modifications; (f) insurance network adequacy standards and balance billing; (g) health care provider workforce in the state; (h) rising health care costs; and (i) non-opiate pain management options.

(a) the need for state statutory and regulatory changes in response to federal actions affecting health care;

(b) Medicaid and reforms to the Medicaid program;

(c) options for increasing state flexibility, including the use of federal waivers;

(d) the state's health insurance marketplace;

(e) health insurance code modifications;

(f) insurance network adequacy standards and balance billing;

(g) health care provider workforce in the state;

(h) rising health care costs; and

(i) non-opiate pain management options.

(6) A final report, including any proposed legislation, shall be presented to the Business and Labor Interim Committee and Health and Human Services Interim Committee before November 30, 2019, and November 30, 2020.